We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Palmer Square Capital BDC
PSBD
$320M
| $634K | ﹤0.01% |
+38,908
| New | +$635K |
|
2177
Limbach Holdings
LMB
$581M
| $634K | ﹤0.01% |
15,300
-1,200
| -7% | -$52.2K |
|
2178
OppFi
OPFI
$803M
| $634K | ﹤0.01% |
253,479
+65,506
| +35% | +$223K |
|
2179
Holley
HLLY
$384M
| $632K | ﹤0.01% |
141,690
-229,350
| -62% | -$1.05M |
|
2180
Kulicke & Soffa
KLIC
$4.78B
| $631K | ﹤0.01% |
12,544
-114,739
| -90% | -$5.74M |
|
2181
Shinhan Financial Group
SHG
$35.6B
| $630K | ﹤0.01% |
+17,747
| New | +$574K |
|
2182
First Busey Corp
BUSE
$2.56B
| $629K | ﹤0.01% |
26,167
+10,920
| +72% | +$256K |
|
2183
e.l.f. Beauty
ELF
$5.81B
| $628K | ﹤0.01% |
3,206
-15,894
| -83% | -$2.82M |
|
2184
UGI
UGI
$7.33B
| $628K | ﹤0.01% |
25,590
-20,056
| -44% | -$482K |
|
2185
Compañía de Cervecerías Unidas
CCU
$2.21B
| $626K | ﹤0.01% |
52,187
-17,841
| -25% | -$213K |
|
2186
Cabaletta Bio
CABA
$455M
| $626K | ﹤0.01% |
36,674
-38,117
| -51% | -$818K |
|
|
HLVX
2187
DELISTED
HilleVax
HLVX
| $626K | ﹤0.01% |
37,622
+7,555
| +25% | +$121K |
|
2188
QuinStreet
QNST
$1.21B
| $626K | ﹤0.01% |
35,426
| – | – |
|
2189
Pagaya Technologies
PGY
$1.78B
| $624K | ﹤0.01% |
61,791
-185,518
| -75% | -$2.63M |
|
2190
Vitamin Cottage Natural Grocers
NGVC
$654M
| $623K | ﹤0.01% |
34,505
-9,484
| -22% | -$152K |
|
2191
F&G Annuities & Life
FG
$3.62B
| $623K | ﹤0.01% |
15,353
+5,447
| +55% | +$228K |
|
2192
Evertec
EVTC
$1.78B
| $622K | ﹤0.01% |
+15,600
| New | +$615K |
|
|
BELFB
2193
Bel Fuse Inc Class B
BELFB
$4.21B
| $621K | ﹤0.01% |
10,297
-12,499
| -55% | -$775K |
|
2194
Steven Madden
SHOO
$3.55B
| $620K | ﹤0.01% |
+14,668
| New | +$618K |
|
2195
Petrobras
PBR
$116B
| $619K | ﹤0.01% |
40,700
-763,896
| -95% | -$12.4M |
|
2196
Regional Management Corp
RM
$303M
| $617K | ﹤0.01% |
25,475
-1,998
| -7% | -$48.1K |
|
2197
Red Rock Resorts
RRR
$3.62B
| $616K | ﹤0.01% |
10,300
-17
| -0.2% | -$943 |
|
|
TYG
2198
Tortoise Energy Infrastructure Corp
TYG
$1.08B
| $615K | ﹤0.01% |
+19,910
| New | +$582K |
|
|
ACB
2199
Aurora Cannabis
ACB
$185M
| $615K | ﹤0.01% |
140,143
-26,487
| -16% | -$103K |
|
2200
iShares MSCI Germany ETF
EWG
$1.68B
| $613K | ﹤0.01% |
+19,300
| New | +$578K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.